BioCentury | Aug 12, 2013
Finance

Abiding no more

...necrosis factor (TNF) alpha mAb. APX002 , an-anti- interleukin-1 (IL-1) beta mAb, is licensed to Jiangsu T-mab BioPharma Co. Ltd....
BioCentury | Nov 22, 2010
Emerging Company Profile

Apexigen: rAbbits Hop Rodents

...the anti-VEGF mAb in cancer. Apexigen's deals with Simcere, 3SBio and a third Chinese partner, Jiangsu T-mab BioPharma Co. Ltd....
...said. Companies and Institutions Mentioned Apexigen Inc. , Burlingame, Calif. Epitomics Inc. , Burlingame, Calif. Jiangsu T-mab BioPharma Co. Ltd....
Items per page:
1 - 2 of 2
BioCentury | Aug 12, 2013
Finance

Abiding no more

...necrosis factor (TNF) alpha mAb. APX002 , an-anti- interleukin-1 (IL-1) beta mAb, is licensed to Jiangsu T-mab BioPharma Co. Ltd....
BioCentury | Nov 22, 2010
Emerging Company Profile

Apexigen: rAbbits Hop Rodents

...the anti-VEGF mAb in cancer. Apexigen's deals with Simcere, 3SBio and a third Chinese partner, Jiangsu T-mab BioPharma Co. Ltd....
...said. Companies and Institutions Mentioned Apexigen Inc. , Burlingame, Calif. Epitomics Inc. , Burlingame, Calif. Jiangsu T-mab BioPharma Co. Ltd....
Items per page:
1 - 2 of 2